Literature DB >> 22318027

OpenVigil--free eyeballs on AERS pharmacovigilance data.

Ruwen Böhm, Jan Höcker, Ingolf Cascorbi, Thomas Herdegen.   

Abstract

Mesh:

Year:  2012        PMID: 22318027     DOI: 10.1038/nbt.2113

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  Making a difference.

Authors: 
Journal:  Nat Biotechnol       Date:  2009-04       Impact factor: 54.908

2.  More eyeballs on AERS.

Authors:  Leslie A Pratt; Paul N Danese
Journal:  Nat Biotechnol       Date:  2009-07       Impact factor: 54.908

Review 3.  [Hypoglycemic risk of insulinotropic drugs].

Authors:  Ruwen Böhm; Ingolf Cascorbi; Thomas Herdegen
Journal:  Med Monatsschr Pharm       Date:  2009-12
  3 in total
  13 in total

1.  Risk of intracranial hypertension with intrauterine levonorgestrel: reply.

Authors:  Mahyar Etminan
Journal:  Ther Adv Drug Saf       Date:  2016-02

2.  Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data.

Authors:  Mayur Sarangdhar; Scott Tabar; Charles Schmidt; Akash Kushwaha; Krish Shah; Jeanine E Dahlquist; Anil G Jegga; Bruce J Aronow
Journal:  Nat Biotechnol       Date:  2016-07-12       Impact factor: 54.908

3.  Revised disproportionality analysis of Mirena and benign intracranial hypertension.

Authors:  Mahyar Etminan
Journal:  Ther Adv Drug Saf       Date:  2017-06-22

4.  Hypnotics and infections: disproportionality analysis of the U.S. Food & Drug Administration adverse event reporting system database.

Authors:  Long Meng; Jing Huang; Qin He; Yibei Zhao; Wenlong Zhao; Juntao Tan; Shusen Sun; Junqing Yang
Journal:  J Clin Sleep Med       Date:  2022-09-01       Impact factor: 4.324

5.  Towards Bridging Translational Gap in Cardiotoxicity Prediction: an Application of Progressive Cardiac Risk Assessment Strategy in TdP Risk Assessment of Moxifloxacin.

Authors:  Nikunjkumar Patel; Oliver Hatley; Alexander Berg; Klaus Romero; Barbara Wisniowska; Debra Hanna; David Hermann; Sebastian Polak
Journal:  AAPS J       Date:  2018-03-14       Impact factor: 4.009

Review 6.  Data mining of the public version of the FDA Adverse Event Reporting System.

Authors:  Toshiyuki Sakaeda; Akiko Tamon; Kaori Kadoyama; Yasushi Okuno
Journal:  Int J Med Sci       Date:  2013-04-25       Impact factor: 3.738

7.  OpenVigil FDA - Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications.

Authors:  Ruwen Böhm; Leocadie von Hehn; Thomas Herdegen; Hans-Joachim Klein; Oliver Bruhn; Holger Petri; Jan Höcker
Journal:  PLoS One       Date:  2016-06-21       Impact factor: 3.240

8.  Ovary and uterus related adverse events associated with statin use: an analysis of the FDA Adverse Event Reporting System.

Authors:  Xue-Feng Jiao; Hai-Long Li; Xue-Yan Jiao; Yuan-Chao Guo; Chuan Zhang; Chun-Song Yang; Li-Nan Zeng; Zhen-Yan Bo; Zhe Chen; Hai-Bo Song; Ling-Li Zhang
Journal:  Sci Rep       Date:  2020-07-20       Impact factor: 4.379

9.  A Pharmacovigilance Study of Hydroxychloroquine Cardiac Safety Profile: Potential Implication in COVID-19 Mitigation.

Authors:  Anand Prakash Singh; Sultan Tousif; Prachi Umbarkar; Hind Lal
Journal:  J Clin Med       Date:  2020-06-15       Impact factor: 4.241

10.  No Relationship of Anti-Androgens to Alzheimer's Disease or Cognitive Disorder in the MedWatch Database.

Authors:  Steven Lehrer; Peter H Rheinstein; Kenneth E Rosenzweig
Journal:  J Alzheimers Dis Rep       Date:  2018-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.